[2] [3] The most common adverse reactions reported in clinical trials include nausea, diarrhea, vomiting, constipation, and abdominal painall gastrointestinal effects that occur in more than 5% of patients
It requires planning, communication with your healthcare provider, careful monitoring (of body weight, appetite, blood sugar, side-effects), and realistic expectations for sustained weight management
Given the frequent coexistence of obesity and T2D with cardiovascular disease and chronic kidney disease (CKD), incretin-based therapies (encompassing selective GLP-1 and multi-receptor agonists) have emerged as disease-modifying treatments across the cardiovascularkidneymetabolic (CKM) spectrum
Do not eat right after your injection
Hypokalemia Risk of hypokalemia because of potential for topiramate to inhibit carbonic anhydrase
+ Is Ipamorelin approved for human use